From September 2008 until August 1, 2018, Dan Troy was Senior Vice President & General Counsel and a member of the Corporate Executive Team of GSK. As General Counsel, he was responsible for leading the company’s legal department in protecting GSK’s intellectual property, managing litigation, supporting business development transactions, as well as risk management.
He was previously a partner at the Washington law firm Sidley Austin, and served as Chief Counsel at the U.S. Food and Drug Administration. Before joining the FDA, he was a partner at Wiley Rein & Fielding, where he practiced constitutional and appellate litigation. He regularly appeared before state and federal appellate courts, including a successful appearance in the U.S. Supreme Court.
Mr. Troy also served in the Justice Department’s Office of Legal Counsel, and clerked for Judge Robert H. Bork on the U.S. Court of Appeals for the DC Circuit. He authored a book, Retroactive Legislation, as well as law review articles, book chapters, and articles in major business and news publications.
EUCATION: Cornell University, B.S.; Columbia University School of Law, J.D.